Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 10, 2009

Global Pharmaceutical Services Partners with Abridge to Expand Services in India

  • Global Pharmaceutical Services (GPSI) inked an exclusive partnership with Abridge Clinical Research, an R&D firm located in Mumbai. The arrangement offers services that include CRO selection for a specific clinical program, monitoring of clinical studies, auditing, quality assurance, design and conduct of Phase I–IV clinical studies, patient enrollment, in-country sponsor representative, medical writing, data management, biostatistical services, and regulatory support.


Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »